首页> 外文OA文献 >Evaluation of the uptake and impact of neonatal vitamin A supplementation delivered through the Lady Health Worker programme on neonatal and infant morbidity and mortality in rural Pakistan: an effectiveness trial
【2h】

Evaluation of the uptake and impact of neonatal vitamin A supplementation delivered through the Lady Health Worker programme on neonatal and infant morbidity and mortality in rural Pakistan: an effectiveness trial

机译:评估新生儿维生素A补充通过女士卫生工作人员对新生儿和婴儿发病率和土耳其农村死亡率的补充的影响:有效性试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Despite evidence for the benefits of vitamin A supplementation (VAS) among children 6 to 59 months of age, the feasibility of introduction and potential benefit of VAS in the neonatal period in public health programmes is uncertain. Objective: The primary objective was to evaluate the feasibility and effectiveness of early neonatal VAS (single dose of 50 000 international units within 48–72 hours after birth) delivered through the public sector Lady Health Worker (LHW) programme in rural Pakistan and to document its association with a reduction in mortality at 6 months of age. Methods: A community-based, cluster randomised, placebo-controlled trial was undertaken in two districts of rural Pakistan. LHWs dispensed vitamin A/placebo in identical capsules to newborn infants within 48–72 hours of birth. Follow-up visits were undertaken at 1 week of age and every 4 weeks thereafter until 6 months of age. Results: Of a total of 15 433 consecutive pregnancies among eligible women of reproductive age, 13 225 pregnancies were registered, 12 218 live births identified and 11 028 newborn infants reached by LHWs. Of these, 5380 (49%) received neonatal VAS and 5648 (51%) placebo. The LHWs successfully delivered the capsules to 79% of newborns within 72 hours of birth with no significant adverse effects. Although the proportion of days observed with symptoms of fever, diarrhoea or rapid breathing were lower with neonatal VAS, these differences were not statistically significant. Mortality rates in the two groups were comparable at 6 months of age. Conclusions: While our study demonstrated that neonatal VAS was safe and could be feasibly delivered by LHWs in Pakistan as part of their early postnatal visits, the overall lack of benefit on neonatal and 6-month morbidity and mortality in our population suggests the need for further evaluation of this intervention in populations at risk.
机译:背景:尽管有证据表明维生素A补充(VAS)在6至59个月的儿童中,但在公共卫生计划中新生儿期间VAS引入和潜在利益的可行性是不确定的。目的:主要目的是评估通过农村巴基斯坦公共部门卫生工作者(LHW)方案的新生儿VAS早期新生儿VAS(单剂量为5万名国际单位)的可行性和有效性它与6个月的死亡率降低的联系。方法:在巴基斯坦农村两个地区进行了基于社区,集群随机,安慰剂对照试验。 LHW在出生时48-72小时内将维生素A /安慰剂分配给新生儿婴儿。后续访问在1周龄和此后每4周进行后续访问,直到6个月。结果:共连续1533次连续怀孕,符合条件的妇女生殖年龄,13名225名怀孕,鉴定了12118个活产出生,11028名新生儿达到LHW达成。其中,5380(49%)接受新生儿VAS和5648(51%)安慰剂。 LHW在出生的72小时内成功地将胶囊送到79%的新生儿,没有显着的不利影响。虽然用新生儿VAS患有发烧症状,腹泻或快速呼吸症状的日子比例,但这些差异没有统计学意义。两组的死亡率在6个月的年龄相当。结论:虽然我们的研究表明,新生儿VAS是安全的,并且可以在巴基斯坦的LHWS在出生后访问的一部分是安全的,但我们人口中的新生儿和6个月发病率和死亡率的整体缺乏缺乏缺乏效果评估危险群体的干预。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号